FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo for Treatment of ESR1-mutated Advanced Breast Cancer Genetics Investing
Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025 Biotech Investing
NRx Pharmaceuticals, Inc. Re-Files Abbreviated New Drug Application for KETAFREE, Preservative-Free IV Ketamine Biotech Investing
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement Biotech Investing
Telescope Innovations Produces Battery-Grade Lithium Carbonate from Recycled Waste Streams Pharmaceutical Investing
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN Biotech Investing
Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich's Ataxia Biotech Investing
"LEQEMBI®" IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in China Biotech Investing
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich's Ataxia Biotech Investing
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Genetics Investing
